The European Center for Disease Prevention and Control said the number of unusual pediatric hepatitis cases reached 450, double the number reported two weeks earlier.
Moderna files for U.S. authorization of COVID shot for kids under 6
Children, Coronavirus Vaccines, COVID-19 Vaccines, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), Omicron BA.2, Pediatric, Pediatric Patients, Pediatric Vaccines, Pediatrics, Pediatrics, TherapeuticsModerna Inc. asked U.S. regulators to authorize the company’s COVID-19 vaccine for children under the age of 6, which would make it the first shot against the coronavirus available for those under 5-years-old.
Children as young as 8 years old should be screened for anxiety and those ages 12 and over for depression, according to new recommendations by the government-backed U.S. Preventive Services Task Force (USPSTF).
Omicron linked to rise in croup in babies; TB vaccine improves immune response to coronavirus
Annals of Neurology, Babies, Bacillus Calmette-Guerin (BCG) Vaccine, Coronavirus, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Studies, Croup, Data, Hospitalized COVID-19 Patients, Immune Response, Omicron (B.1.1.529) (South Africa), Pediatrics, R&D, Research, Respiratory Conditions, Toddlers, Tuberculosis, VentilatorsThe Omicron variant of the coronavirus is causing a dramatic rise in cases of croup, a dangerous respiratory condition usually seen in babies and toddlers, new data suggest. Additionally, new research sheds light on how a tuberculosis vaccine might help protect against COVID-19.
The U.S. Food and Drug Administration approved AbbVie’s Dalvance (dalbavancin) for acute bacterial skin and skin structure infections in pediatric patients as young as newborns.
Topline results from two of Merck’s Phase III pediatric trials show the company’s investigational 15-valent pneumococcal conjugate vaccine, V114, may be safe and effective in healthy children.
The U.S. Food and Drug Administration approved BioCryst Pharmaceuticals Inc.’s Orladeyo (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema in adults and young patients 12 years and older.
Covid-19 Vaccine Frontrunners Still Largely Untested in Children
BioNTech, Business, Children, COVID-19 Testing, COVID-19 Vaccines, Dr. Anthony Fauci (Director), Emergency Use Authorization, FDA, First Responders, Health Workers, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), Pediatrics, Pfizer, The Washington Post, U.S. Centers for Disease Control and Prevention, United KingdomAnthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), noted that it would take time – possibly months – before people 18 years of age and younger could get a Covid-19 vaccine because clinical trials were either underway or had not yet begun.
Syneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.
The United States Food and Drug Administration approved Bayer’s Lampit (nifurtimox) for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.